Dividend-adjusted return from the previous close · S&P 500 uses VOOSBIOS&P 500 · VOO
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | +5.6% | +3.4% | −16.9% | +8.9% | +27.5% | +133.3% | +25.7% | +143.9% |
| Peer average | +0.8% | +5.8% | +2.9% | +20.5% | +29.5% | +75.3% | +27.5% | — |
| S&P 500 · VOO | +0.3% | −5.0% | −4.6% | +8.7% | +9.8% | +80.8% | +71.8% | — |
Key Statistics
Open all fund facts →- AUM
- $177M
- Expense ratio
- 0.50%
- Distribution yield
- 0.0%
- NAV
- $52.81
- Volume
- 18K
- Avg. volume 30D
- 34K
- High today
- $55.92
- Low today
- $52.92
- Previous close
- $52.83
- 52-week high
- $70.85
- 52-week low
- $43.10
- Our risk indicator
- 4/5
SBIO in One Breath
SBIO Among Health Care ETFs
YTDEnd-of-day Nov 6, 2026 · 33 Health care ETFs by YTD
$10,000 in SBIO
5Y$10,000 in SBIO became
$12,566
In the S&P 500 (VOO)
$17,177
Total return, dividends in · Oct 29, 2021 – Nov 6, 2026 · S&P 500 uses VOO
SBIO’s Top Holdings
TodayORKAOruka Therapeutics4.4%CGON4.0%MANE3.7%DNTH3.2%TVTX3.2%EWTX2.9%DFTX2.8%RLAY2.6%ACAD2.5%XENE2.5%AMLX2.4%DYN2.2%VRDN2.2%DNLI2.2%IRON2.1%TARS2.1%IDYA2.0%VCEL1.8%ZLAB1.8%XNCR1.8%MBX1.6%81 more
Biotechnology
ALPS SBIO · 103 holdings · tile size = share of the fund · as of Nov 6, 2026
What SBIO Holds
TodayBiotechnology93.2%
ORKA 4.4 · CGON 4.0 · MANE 3.7 · DNTH 3.2 · TVTX 3.2 · EWTX 2.9 · DFTX 2.8
Medical - Diagnostics & Research0.4%
FLGT
Medical - Devices0.3%
DCTH
Other holdings6.1%
MGTX · SLDB · CADL · DSGN · AVBP · OLMA · ALT
ALPS SBIO · share of the fund by industry · as of Nov 6, 2026
Oruka’s Share of SBIO
Today4.4%
$44 of every $1,000 in SBIO is Oruka
Oruka held by SBIO
$7.8M
ALPS SBIO · each square = $10 of $1,000 · as of Nov 6, 2026
SBIO’s Share of Health Care ETFs
Today0.2%
of the $112B in 39 Health care ETFs
$177M0.2%
$50.9B45.4%
$19.1B17.0%
$41.9B37.4%
Health care ETF AUM · Nov 6, 2026
SBIO Fee per $100 vs Peers
TodayExpense ratio · Health care peers · Nov 6, 2026
Inside SBIO
103 holdings · as of Nov 6, 2026SBIO
ALPS Medical Breakthroughs ETF
Today| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | ORKA | Oruka Therapeutics | 4.40% |
| 2 | CGON | CG oncology | 3.97% |
| 3 | MANE | VeraDermics | 3.72% |
| 4 | DNTH | Dianthus Therapeutics | 3.21% |
| 5 | TVTX | Travere Therapeutics | 3.18% |
| 6 | EWTX | Edgewise Therapeutics | 2.92% |
| 7 | DFTX | Definium Therapeutics | 2.82% |
| 8 | RLAY | Relay Therapeutics | 2.58% |
| 9 | ACAD | ACADIA Pharmaceuticals | 2.53% |
| 10 | XENE | Xenon Pharmaceuticals | 2.53% |
BiotechnologyMedical - DiagnosticsMedical - DevicesOther
ALPS SBIO · current holdings by weight · as of Nov 6, 2026 · each tile is one holding · top 20 = 52.4%
All SBIO Holdings
104 holdings · as of Nov 6, 2026SBIO
SBIO’s Holdings
Today| # | ||||||
|---|---|---|---|---|---|---|
| 1 | ORKAOruka Therapeutics | Healthcare | 4.40% | $439.59 | 81K | $7.8M |
| 2 | CGONCG oncology | Healthcare | 3.97% | $396.88 | 108K | $7.0M |
| 3 | MANEVeraDermics | Healthcare | 3.72% | $371.85 | 51K | $6.6M |
| 4 | DNTHDianthus Therapeutics | Healthcare | 3.21% | $321.24 | 68K | $5.7M |
| 5 | TVTXTravere Therapeutics | Healthcare | 3.18% | $318.02 | 115K | $5.6M |
| 6 | EWTXEdgewise Therapeutics | Healthcare | 2.92% | $291.68 | 133K | $5.2M |
| 7 | DFTXDefinium Therapeutics | Healthcare | 2.82% | $281.81 | 164K | $5.0M |
| 8 | RLAYRelay Therapeutics | Healthcare | 2.58% | $257.83 | 268K | $4.6M |
| 9 | ACADACADIA Pharmaceuticals | Healthcare | 2.53% | $252.73 | 210K | $4.5M |
| 10 | XENEXenon Pharmaceuticals | Healthcare | 2.53% | $252.52 | 119K | $4.5M |
| 11 | AMLXAmylyx Pharmaceuticals | Healthcare | 2.40% | $239.96 | 154K | $4.2M |
| 12 | DYNDyne Therapeutics | Healthcare | 2.24% | $224.37 | 229K | $4.0M |
| 13 | VRDNViridian Therapeutics | Healthcare | 2.24% | $223.83 | 139K | $4.0M |
| 14 | DNLIDenali Therapeutics | Healthcare | 2.18% | $218.16 | 196K | $3.9M |
| 15 | IRONDisc Medicine | Healthcare | 2.08% | $208.45 | 47K | $3.7M |
ALPS SBIO · every reported holding · per $10,000 = dollars of each holding in a $10,000 stake · as of Nov 6, 2026
How It Compares
SBIO
ALPS Medical Breakthroughs ETF’s Peers
YTDHealth care peers · YTD and past-year returns · as of Nov 7, 2026 · sorted by AUM
Head to Head
Put SBIO head to head with XLV →XLV vs SBIO
YTDYear to date
XLV wins+12.0 pts
Past year
XLV wins+1.5 pts
Fee
XLV winslower fee
Yield
XLV wins+1.4 pts
AUM
XLV287.9× more
4–0XLV wins
SPDR XLV and ALPS SBIO · year-to-date · as of Nov 7, 2026 · AUM not scored
SBIO vs VOO
YTDSBIO · ALPS Medical Breakthroughs
+8.9%
VOO · S&P 500
+8.7%
Gap
0.2 pts
ALPS SBIO and Vanguard VOO · YTD total return · as of Nov 7, 2026
SBIO vs Its Peer Average
YTDSBIOAvsBPeer average
1D+5.6%+0.8%
1M+3.4%+5.8%
3M−16.9%+2.9%
YTD+8.9%+20.5%
1Y+27.5%+29.5%
3Y+133.3%+75.3%
5Y+25.7%+27.5%
2–5Peer average wins
38 Health care peers · each row scaled to its leader
The Details
SBIO
Risk
1Y4/5our risk indicator
CalmerBumpier
Volatility · 1Y33.30%
Deepest drop · 1Y−29.2%
Lowest point · 5Y−47.9%
52-week range
$55.78
$43.10−21.3% from the high$70.85
ALPS SBIO · past-year price moves · as of Nov 7, 2026
SBIO
Fund Facts
Today2014launched Dec 30
Tracks[…]
Exchange · CUSIPAMEX · 00162Q593
StructureETF
Leverage1x
Cost on $10,000$50 a year
Go deeper
ALPS SBIO · fund facts · as of Nov 7, 2026
SBIO
Payouts by Year
5Y$1.17per share, Dec 2024
Distribution yield0.0%
PaidOnce a year, in December
Latest ex-date · paidDec 19 · Dec 26, 2024
5 payouts added up$2.62 a share
ALPS SBIO · distributions by ex-date · 2017–2024
All Fund FactsDocuments · trading · fees · every payout
Prospectus & Documents
SEC reported portfolio · 2026-08-31 ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2026-05-31 ↗SEC reported portfolio · 2026-02-28 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-11-30 ↗SEC reported portfolio · 2025-08-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-05-31 ↗SEC reported portfolio · 2025-02-28 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2024-11-30 ↗SEC reported portfolio · 2024-08-31 ↗SEC reported portfolio · 2024-05-31 ↗SEC reported portfolio · 2024-02-29 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2023-11-30 ↗SEC reported portfolio · 2023-08-31 ↗SEC reported portfolio · 2023-05-31 ↗SEC reported portfolio · 2023-02-28 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2022-11-30 ↗SEC reported portfolio · 2022-08-31 ↗SEC reported portfolio · 2022-05-31 ↗SEC reported portfolio · 2022-02-28 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2021-11-30 ↗SEC reported portfolio · 2021-08-31 ↗SEC reported portfolio · 2021-05-31 ↗SEC reported portfolio · 2021-02-28 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2020-11-30 ↗SEC reported portfolio · 2020-08-31 ↗SEC reported portfolio · 2020-05-31 ↗
Trading & Liquidity
Net asset value$52.81
Premium / discount[…]
Median spread · 30D[…]
Volume today18K
Average volume · 30D34K
Shares outstanding[…]
Options[…]
Fees & Costs
Net expense ratio0.50%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$50.00
Our risk indicator4/5
Estimated yearly cost excludes trading costs and assumes constant assets.
Distributions
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 19, 2024 | Dec 26, 2024 | $1.17 |
| Dec 21, 2023 | Dec 27, 2023 | $0.0711 |
| Dec 19, 2019 | Dec 27, 2019 | $0.0158 |
| Dec 20, 2018 | Dec 27, 2018 | $0.78 |
| Dec 21, 2017 | Dec 28, 2017 | $0.58 |
Issuer contentFrom ALPSHear the strategy from the people behind SBIO.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →